Global Rheumatoid Arthritis Diagnosis Tests Market by Test Type (Monitoring Rheumatoid Arthritis Treatment Efficiency Tests, Serology Test), End-User (Diagnostic Centers, Hospitals & Clinics) - Forecast 2024-2030- Product Image

Sale

Global Rheumatoid Arthritis Diagnosis Tests Market by Test Type (Monitoring Rheumatoid Arthritis Treatment Efficiency Tests, Serology Test), End-User (Diagnostic Centers, Hospitals & Clinics) - Forecast 2024-2030

Report
196 Pages
March 2024
Region: Global
360iResearch™
ID: 5675131

UP TO €845EUR$875USD£723GBP OFF until Dec 31^st 2024

The Rheumatoid Arthritis Diagnosis Tests Market size was estimated at USD 2.98 billion in 2023, USD 3.08 billion in 2024, and is expected to grow at a CAGR of 4.69% to reach USD 4.11 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Rheumatoid Arthritis Diagnosis Tests Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Rheumatoid Arthritis Diagnosis Tests Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Rheumatoid Arthritis Diagnosis Tests Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Apollo Health and Lifestyle Limited, Arthritis Society Canada, Augurex Life Sciences Corporation, Beckman Coulter, Inc., Bio-Rad Laboratories Inc., Exagen Inc., F. Hoffmann-La Roche AG, Genway Biotech, Inc., Laboratory Corporation of America Holdings, QIAGEN GmbH, Remission Medical, Siemens Healthineers, Svar Life Sciences AB, and Thermo Fisher Scientific, Inc.

Market Segmentation & Coverage

This research report categorizes the Rheumatoid Arthritis Diagnosis Tests Market to forecast the revenues and analyze trends in each of the following sub-markets:

Test Type
- Monitoring Rheumatoid Arthritis Treatment Efficiency Tests
  - Creatinine Test
  - Muscle Enzyme Tests
  - Salicylate Level Count
- Serology Test
  - Anti-Cyclic Citrullinated Peptide
  - Antinuclear Antibody
  - Erythrocyte Sedimentation Rate
  - Rheumatoid Factor (RF)
  - Uric Acid
End-User
- Diagnostic Centers
- Hospitals & Clinics

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

What is the market size and forecast of the Rheumatoid Arthritis Diagnosis Tests Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Rheumatoid Arthritis Diagnosis Tests Market?
What are the technology trends and regulatory frameworks in the Rheumatoid Arthritis Diagnosis Tests Market?
What is the market share of the leading vendors in the Rheumatoid Arthritis Diagnosis Tests Market?
Which modes and strategic moves are suitable for entering the Rheumatoid Arthritis Diagnosis Tests Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Rheumatoid Arthritis Diagnosis Tests Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of rheumatoid arthritis worldwide
5.1.1.2. Growing expenditure for the treatment and management of RA
5.1.1.3. Awareness initiatives about RA by governments and global institutions
5.1.2. Restraints
5.1.2.1. Patients’ reluctance to access healthcare services for RA
5.1.3. Opportunities
5.1.3.1. Improvements in MRI, ultrasound, and HR-pQCT imaging tests and development of serum biomarker panel
5.1.3.2. Ongoing research activities for the diagnosis of RA
5.1.4. Challenges
5.1.4.1. Limited specificity and sensitivity of test kits
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Rheumatoid Arthritis Diagnosis Tests Market, by Test Type

6.1. Introduction
6.2. Monitoring Rheumatoid Arthritis Treatment Efficiency Tests
6.3.1. Creatinine Test
6.3.2. Muscle Enzyme Tests
6.3.3. Salicylate Level Count
6.3. Serology Test
6.4.1. Anti-Cyclic Citrullinated Peptide
6.4.2. Antinuclear Antibody
6.4.3. Erythrocyte Sedimentation Rate
6.4.4. Rheumatoid Factor (RF)
6.4.5. Uric Acid

7. Rheumatoid Arthritis Diagnosis Tests Market, by End-User

7.1. Introduction
7.2. Diagnostic Centers
7.3. Hospitals & Clinics

8. Americas Rheumatoid Arthritis Diagnosis Tests Market

8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Rheumatoid Arthritis Diagnosis Tests Market

9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Rheumatoid Arthritis Diagnosis Tests Market

10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape

11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio

12.1. Key Company Profiles
12.1.1. Abbott Laboratories
12.1.2. Apollo Health and Lifestyle Limited
12.1.3. Arthritis Society Canada
12.1.4. Augurex Life Sciences Corporation
12.1.5. Beckman Coulter, Inc.
12.1.6. Bio-Rad Laboratories Inc.
12.1.7. Exagen Inc.
12.1.8. F. Hoffmann-La Roche AG
12.1.9. Genway Biotech, Inc.
12.1.10. Laboratory Corporation of America Holdings
12.1.11. QIAGEN GmbH
12.1.12. Remission Medical
12.1.13. Siemens Healthineers
12.1.14. Svar Life Sciences AB
12.1.15. Thermo Fisher Scientific, Inc.
12.2. Key Product Portfolio

13. Appendix

13.1. Discussion Guide
13.2. License & Pricing

List of Figures

FIGURE 1. RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET RESEARCH PROCESS
FIGURE 2. RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, 2023 VS 2030
FIGURE 3. RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET DYNAMICS
FIGURE 7. RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
FIGURE 8. RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 10. RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 12. AMERICAS RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 14. UNITED STATES RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 20. RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 6. RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY MONITORING RHEUMATOID ARTHRITIS TREATMENT EFFICIENCY TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY MONITORING RHEUMATOID ARTHRITIS TREATMENT EFFICIENCY TESTS, 2018-2030 (USD MILLION)
TABLE 8. RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY CREATININE TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY MUSCLE ENZYME TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY SALICYLATE LEVEL COUNT, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY SEROLOGY TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY SEROLOGY TEST, 2018-2030 (USD MILLION)
TABLE 13. RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY ANTI-CYCLIC CITRULLINATED PEPTIDE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY ANTINUCLEAR ANTIBODY, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY ERYTHROCYTE SEDIMENTATION RATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY RHEUMATOID FACTOR (RF), BY REGION, 2018-2030 (USD MILLION)
TABLE 17. RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY URIC ACID, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 19. RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY MONITORING RHEUMATOID ARTHRITIS TREATMENT EFFICIENCY TESTS, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY SEROLOGY TEST, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY MONITORING RHEUMATOID ARTHRITIS TREATMENT EFFICIENCY TESTS, 2018-2030 (USD MILLION)
TABLE 28. ARGENTINA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY SEROLOGY TEST, 2018-2030 (USD MILLION)
TABLE 29. ARGENTINA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 30. BRAZIL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 31. BRAZIL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY MONITORING RHEUMATOID ARTHRITIS TREATMENT EFFICIENCY TESTS, 2018-2030 (USD MILLION)
TABLE 32. BRAZIL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY SEROLOGY TEST, 2018-2030 (USD MILLION)
TABLE 33. BRAZIL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 34. CANADA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 35. CANADA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY MONITORING RHEUMATOID ARTHRITIS TREATMENT EFFICIENCY TESTS, 2018-2030 (USD MILLION)
TABLE 36. CANADA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY SEROLOGY TEST, 2018-2030 (USD MILLION)
TABLE 37. CANADA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 38. MEXICO RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 39. MEXICO RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY MONITORING RHEUMATOID ARTHRITIS TREATMENT EFFICIENCY TESTS, 2018-2030 (USD MILLION)
TABLE 40. MEXICO RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY SEROLOGY TEST, 2018-2030 (USD MILLION)
TABLE 41. MEXICO RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY MONITORING RHEUMATOID ARTHRITIS TREATMENT EFFICIENCY TESTS, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY SEROLOGY TEST, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 47. ASIA-PACIFIC RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 48. ASIA-PACIFIC RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY MONITORING RHEUMATOID ARTHRITIS TREATMENT EFFICIENCY TESTS, 2018-2030 (USD MILLION)
TABLE 49. ASIA-PACIFIC RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY SEROLOGY TEST, 2018-2030 (USD MILLION)
TABLE 50. ASIA-PACIFIC RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 51. ASIA-PACIFIC RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 52. AUSTRALIA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 53. AUSTRALIA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY MONITORING RHEUMATOID ARTHRITIS TREATMENT EFFICIENCY TESTS, 2018-2030 (USD MILLION)
TABLE 54. AUSTRALIA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY SEROLOGY TEST, 2018-2030 (USD MILLION)
TABLE 55. AUSTRALIA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 56. CHINA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 57. CHINA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY MONITORING RHEUMATOID ARTHRITIS TREATMENT EFFICIENCY TESTS, 2018-2030 (USD MILLION)
TABLE 58. CHINA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY SEROLOGY TEST, 2018-2030 (USD MILLION)
TABLE 59. CHINA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 60. INDIA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 61. INDIA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY MONITORING RHEUMATOID ARTHRITIS TREATMENT EFFICIENCY TESTS, 2018-2030 (USD MILLION)
TABLE 62. INDIA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY SEROLOGY TEST, 2018-2030 (USD MILLION)
TABLE 63. INDIA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 64. INDONESIA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 65. INDONESIA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY MONITORING RHEUMATOID ARTHRITIS TREATMENT EFFICIENCY TESTS, 2018-2030 (USD MILLION)
TABLE 66. INDONESIA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY SEROLOGY TEST, 2018-2030 (USD MILLION)
TABLE 67. INDONESIA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 68. JAPAN RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 69. JAPAN RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY MONITORING RHEUMATOID ARTHRITIS TREATMENT EFFICIENCY TESTS, 2018-2030 (USD MILLION)
TABLE 70. JAPAN RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY SEROLOGY TEST, 2018-2030 (USD MILLION)
TABLE 71. JAPAN RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 72. MALAYSIA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 73. MALAYSIA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY MONITORING RHEUMATOID ARTHRITIS TREATMENT EFFICIENCY TESTS, 2018-2030 (USD MILLION)
TABLE 74. MALAYSIA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY SEROLOGY TEST, 2018-2030 (USD MILLION)
TABLE 75. MALAYSIA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 76. PHILIPPINES RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 77. PHILIPPINES RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY MONITORING RHEUMATOID ARTHRITIS TREATMENT EFFICIENCY TESTS, 2018-2030 (USD MILLION)
TABLE 78. PHILIPPINES RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY SEROLOGY TEST, 2018-2030 (USD MILLION)
TABLE 79. PHILIPPINES RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 80. SINGAPORE RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 81. SINGAPORE RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY MONITORING RHEUMATOID ARTHRITIS TREATMENT EFFICIENCY TESTS, 2018-2030 (USD MILLION)
TABLE 82. SINGAPORE RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY SEROLOGY TEST, 2018-2030 (USD MILLION)
TABLE 83. SINGAPORE RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 84. SOUTH KOREA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 85. SOUTH KOREA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY MONITORING RHEUMATOID ARTHRITIS TREATMENT EFFICIENCY TESTS, 2018-2030 (USD MILLION)
TABLE 86. SOUTH KOREA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY SEROLOGY TEST, 2018-2030 (USD MILLION)
TABLE 87. SOUTH KOREA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 88. TAIWAN RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 89. TAIWAN RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY MONITORING RHEUMATOID ARTHRITIS TREATMENT EFFICIENCY TESTS, 2018-2030 (USD MILLION)
TABLE 90. TAIWAN RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY SEROLOGY TEST, 2018-2030 (USD MILLION)
TABLE 91. TAIWAN RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 92. THAILAND RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 93. THAILAND RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY MONITORING RHEUMATOID ARTHRITIS TREATMENT EFFICIENCY TESTS, 2018-2030 (USD MILLION)
TABLE 94. THAILAND RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY SEROLOGY TEST, 2018-2030 (USD MILLION)
TABLE 95. THAILAND RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 96. VIETNAM RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 97. VIETNAM RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY MONITORING RHEUMATOID ARTHRITIS TREATMENT EFFICIENCY TESTS, 2018-2030 (USD MILLION)
TABLE 98. VIETNAM RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY SEROLOGY TEST, 2018-2030 (USD MILLION)
TABLE 99. VIETNAM RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY MONITORING RHEUMATOID ARTHRITIS TREATMENT EFFICIENCY TESTS, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY SEROLOGY TEST, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 105. DENMARK RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 106. DENMARK RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY MONITORING RHEUMATOID ARTHRITIS TREATMENT EFFICIENCY TESTS, 2018-2030 (USD MILLION)
TABLE 107. DENMARK RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY SEROLOGY TEST, 2018-2030 (USD MILLION)
TABLE 108. DENMARK RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 109. EGYPT RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 110. EGYPT RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY MONITORING RHEUMATOID ARTHRITIS TREATMENT EFFICIENCY TESTS, 2018-2030 (USD MILLION)
TABLE 111. EGYPT RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY SEROLOGY TEST, 2018-2030 (USD MILLION)
TABLE 112. EGYPT RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 113. FINLAND RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 114. FINLAND RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY MONITORING RHEUMATOID ARTHRITIS TREATMENT EFFICIENCY TESTS, 2018-2030 (USD MILLION)
TABLE 115. FINLAND RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY SEROLOGY TEST, 2018-2030 (USD MILLION)
TABLE 116. FINLAND RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 117. FRANCE RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 118. FRANCE RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY MONITORING RHEUMATOID ARTHRITIS TREATMENT EFFICIENCY TESTS, 2018-2030 (USD MILLION)
TABLE 119. FRANCE RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY SEROLOGY TEST, 2018-2030 (USD MILLION)
TABLE 120. FRANCE RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 121. GERMANY RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 122. GERMANY RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY MONITORING RHEUMATOID ARTHRITIS TREATMENT EFFICIENCY TESTS, 2018-2030 (USD MILLION)
TABLE 123. GERMANY RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY SEROLOGY TEST, 2018-2030 (USD MILLION)
TABLE 124. GERMANY RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 125. ISRAEL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 126. ISRAEL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY MONITORING RHEUMATOID ARTHRITIS TREATMENT EFFICIENCY TESTS, 2018-2030 (USD MILLION)
TABLE 127. ISRAEL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY SEROLOGY TEST, 2018-2030 (USD MILLION)
TABLE 128. ISRAEL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 129. ITALY RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 130. ITALY RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY MONITORING RHEUMATOID ARTHRITIS TREATMENT EFFICIENCY TESTS, 2018-2030 (USD MILLION)
TABLE 131. ITALY RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY SEROLOGY TEST, 2018-2030 (USD MILLION)
TABLE 132. ITALY RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 133. NETHERLANDS RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 134. NETHERLANDS RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY MONITORING RHEUMATOID ARTHRITIS TREATMENT EFFICIENCY TESTS, 2018-2030 (USD MILLION)
TABLE 135. NETHERLANDS RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY SEROLOGY TEST, 2018-2030 (USD MILLION)
TABLE 136. NETHERLANDS RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 137. NIGERIA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 138. NIGERIA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY MONITORING RHEUMATOID ARTHRITIS TREATMENT EFFICIENCY TESTS, 2018-2030 (USD MILLION)
TABLE 139. NIGERIA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY SEROLOGY TEST, 2018-2030 (USD MILLION)
TABLE 140. NIGERIA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 141. NORWAY RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 142. NORWAY RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY MONITORING RHEUMATOID ARTHRITIS TREATMENT EFFICIENCY TESTS, 2018-2030 (USD MILLION)
TABLE 143. NORWAY RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY SEROLOGY TEST, 2018-2030 (USD MILLION)
TABLE 144. NORWAY RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 145. POLAND RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 146. POLAND RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY MONITORING RHEUMATOID ARTHRITIS TREATMENT EFFICIENCY TESTS, 2018-2030 (USD MILLION)
TABLE 147. POLAND RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY SEROLOGY TEST, 2018-2030 (USD MILLION)
TABLE 148. POLAND RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 149. QATAR RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 150. QATAR RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY MONITORING RHEUMATOID ARTHRITIS TREATMENT EFFICIENCY TESTS, 2018-2030 (USD MILLION)
TABLE 151. QATAR RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY SEROLOGY TEST, 2018-2030 (USD MILLION)
TABLE 152. QATAR RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 153. RUSSIA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 154. RUSSIA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY MONITORING RHEUMATOID ARTHRITIS TREATMENT EFFICIENCY TESTS, 2018-2030 (USD MILLION)
TABLE 155. RUSSIA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY SEROLOGY TEST, 2018-2030 (USD MILLION)
TABLE 156. RUSSIA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY MONITORING RHEUMATOID ARTHRITIS TREATMENT EFFICIENCY TESTS, 2018-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY SEROLOGY TEST, 2018-2030 (USD MILLION)
TABLE 160. SAUDI ARABIA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY MONITORING RHEUMATOID ARTHRITIS TREATMENT EFFICIENCY TESTS, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY SEROLOGY TEST, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 165. SPAIN RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 166. SPAIN RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY MONITORING RHEUMATOID ARTHRITIS TREATMENT EFFICIENCY TESTS, 2018-2030 (USD MILLION)
TABLE 167. SPAIN RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY SEROLOGY TEST, 2018-2030 (USD MILLION)
TABLE 168. SPAIN RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 169. SWEDEN RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 170. SWEDEN RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY MONITORING RHEUMATOID ARTHRITIS TREATMENT EFFICIENCY TESTS, 2018-2030 (USD MILLION)
TABLE 171. SWEDEN RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY SEROLOGY TEST, 2018-2030 (USD MILLION)
TABLE 172. SWEDEN RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 173. SWITZERLAND RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 174. SWITZERLAND RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY MONITORING RHEUMATOID ARTHRITIS TREATMENT EFFICIENCY TESTS, 2018-2030 (USD MILLION)
TABLE 175. SWITZERLAND RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY SEROLOGY TEST, 2018-2030 (USD MILLION)
TABLE 176. SWITZERLAND RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 177. TURKEY RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 178. TURKEY RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY MONITORING RHEUMATOID ARTHRITIS TREATMENT EFFICIENCY TESTS, 2018-2030 (USD MILLION)
TABLE 179. TURKEY RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY SEROLOGY TEST, 2018-2030 (USD MILLION)
TABLE 180. TURKEY RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY MONITORING RHEUMATOID ARTHRITIS TREATMENT EFFICIENCY TESTS, 2018-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY SEROLOGY TEST, 2018-2030 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 186. UNITED KINGDOM RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY MONITORING RHEUMATOID ARTHRITIS TREATMENT EFFICIENCY TESTS, 2018-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY SEROLOGY TEST, 2018-2030 (USD MILLION)
TABLE 188. UNITED KINGDOM RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 189. RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 190. RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 191. RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET LICENSE & PRICING

Companies Mentioned

Abbott Laboratories
Apollo Health and Lifestyle Limited
Arthritis Society Canada
Augurex Life Sciences Corporation
Beckman Coulter, Inc.
Bio-Rad Laboratories Inc.
Exagen Inc.
F. Hoffmann-La Roche AG
Genway Biotech, Inc.
Laboratory Corporation of America Holdings
QIAGEN GmbH
Remission Medical
Siemens Healthineers
Svar Life Sciences AB
Thermo Fisher Scientific, Inc.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	196
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 3.08 Billion
Forecasted Market Value ( USD ) by 2030	$ 4.11 Billion
Compound Annual Growth Rate	4.6%
Regions Covered	Global
No. of Companies Mentioned	15

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3259EUR$3,374USD£2,789GBP €3621EUR$3,749USD£3,099GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4128EUR$4,274USD£3,533GBP €4587EUR$4,749USD£3,925GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€4997EUR$5,174USD£4,276GBP €5552EUR$5,749USD£4,752GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5866EUR$6,074USD£5,020GBP €6518EUR$6,749USD£5,578GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7605EUR$7,874USD£6,508GBP €8450EUR$8,749USD£7,231GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects:

The report addresses key questions such as:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Rheumatoid Arthritis Diagnosis Tests - Global Strategic Business Report

Rheumatoid Arthritis Diagnosis Tests Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

Rheumatoid Arthritis Diagnostic Tests - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

Autoimmune Disease Diagnostics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2024 - 2029

Autoimmune Disease Testing Market Forecasts from 2023 to 2028

About the Rheumatoid Arthritis Test Market